Receptal System Liners and Canisters 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Hospira Inc 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-09-17
  • 사례 출판 날짜
    2013-09-17
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: hospira receptal system liners and canisters the medicines and healthcare products regulatory agency (mhra), united kingdom (uk) posted a medical device safety alert concerning receptal system liners and canisters manufactured by hospira inc. hospira has become aware that customers may be inappropriately using incorrectly sized receptal liners with receptal canisters (e.G. 1.5l liner, 2l liner or 3l liner with a 1l canister). to date, hospira has received reports associated with this practice, including one case resulted in serious injury and one case resulted in death. hospira explains that the lid may not fit and the suction will not be sufficient and/or consistent if incorrectly sized liners are used. if suction is compromised during a general surgical procedure, the fluids may impair the surgeon’s vision and ability to expeditiously complete the procedure. the harm includes progression of the untreated condition that may result in symptoms such as hypertension, tachycardia, and bradycardia. furthermore, the delay may result in a prolonged exposure to any anaesthesia used during the procedure. compromised suction leads to diminished efficacy of the product and/or delay in therapy, both of which can result in life threatening situations if airway clearance or gastric suction is needed. therefore, hospira recommends that hospira/abbott canisters should only be used with appropriately sized hospira/abbott receptal lid/ liners. hospira recommends the users to follow the receptal set up instructions which reminds the users to fully extend and insert the liner. in addition, hospira will update the instructions for use to reflect the appropriate use of the affected products. for instance, a 1l liner should be matched with a 1l canister and hospira/abbott liners should be matched with hospira/abbott canister. for details, please visit the following mhra website: http://www.Mhra.Gov.Uk/safetyinformation/safetywarningsalertsandrecalls/fieldsafetynotices/con314890 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 17 september 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Hospira Receptal System Liners and Canisters
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DH